The Director evaluates and determines any additional reasons for noncompliance and ensures staff have a current local intranasal naloxone policy.
Questioned Costs
$0
Funds for Better Use
$0
Recommendation Status
Closed
Source UUID
21-03308-24-06
Recommendation Number
06
Significant Recommendation
No